TIRZEPATIDE
THERAPY

TIRZEPATIDE is a daul action GLP-1 (glucagon-like peptide-1) and GIP (Gastric inhibitory polypeptide) medication that offers a number of health benefits. GLP-1/ GIP medications may promote weight loss and the maintenance of a healthy bodyweight through several pathways. These medications are also able to normalize blood sugar levels, thereby improving A1C levels and may decrease the occurrence of cardiac events. GLP-1/ GIP medications work by mimicking a hormone produced in our bodies when we consume food. This results in decreased intestinal motility so you will feel fuller longer thereby decreasing hunger. Blood sugar levels are normalized, in part, by reducing the production of sugar in the liver and through stimulation of insulin secretion by the pancreas.

Benefits of compounded TIRZEPATIDE therapy may include:

* Decreased appetite and reduced cravings

* Weight loss

* A1C reduction

* Improved cardiovascular health

Standard Dosing Protocol:

Tirzepatide

Weeks 1-4: 2.5mg injected subcutaneously once weekly

Weeks 5-8: 5mg injected subcutaneously once weekly

Weeks 9-12: 7.5mg injected subcutaneously once weekly

Weeks 13-16: 10mg injected subcutaneously once weekly

Weeks 17 plus: 15mg injected subcutaneously once weekly